30
Participants
Start Date
October 1, 2024
Primary Completion Date
September 30, 2031
Study Completion Date
September 30, 2031
Repotrectinib
Repotrectinib 160 mg BID, until progression or unacceptable toxicity
RECRUITING
CH Aix-en-Provence, Aix-en-Provence
RECRUITING
AP-HM, Marseille
RECRUITING
HIA Sainte Anne, Toulon
RECRUITING
CHU Angers, Angers
RECRUITING
CHU Bordeaux, Bordeaux
RECRUITING
CHU Brest, Brest
RECRUITING
Centre François Baclesse, Caen
RECRUITING
CH Chambéry, Chambéry
RECRUITING
Hôpitaux civils de Colmar, Colmar
RECRUITING
CHI Créteil, Créteil
RECRUITING
CHD Vendée, La Roche-sur-Yon
RECRUITING
CHRU Lille, Lille
RECRUITING
CHU Limoges, Limoges
RECRUITING
Hospices Civils de Lyon, Lyon
RECRUITING
CH Cornouaille, Quimper
RECRUITING
CHU Rennes, Rennes
RECRUITING
CHU Rouen, Rouen
RECRUITING
Hôpital Foch, Suresnes
RECRUITING
CHU Toulouse, Toulouse
RECRUITING
Hôpitaux Nord-Ouest, Villefranche-sur-Saône
Groupe Francais De Pneumo-Cancerologie
OTHER
Hospices Civils de Lyon
OTHER
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
OTHER